 |
United States Pediatric Vaccines Market, Doses, Immunization (Vaccinated), Cases & Forecast
Pediatric Vaccines market for United States is a multi-billion dollar industry. The value of United States pediatric vaccines market alone is expected to reach more than US$ 18 Billion by 2020. The United States Pediatric vaccines market is driven by favorable demographics, growing public acceptance and product innovation. Varicella and Pneumococcal vaccines (PCV) control the highest and second highest market share in United States respectively. Together both of these vaccines control more than 50% market share.
In number of cases Polio, MMR, Diphtheria and Tetanus cases have diminished significantly from the year 2001 till 2013. In United States, DTP are the highly penetrated vaccines in pediatric vaccines market which contributed more than 100 Million doses in 2014. Polio and MMR are also mostly used vaccines together they consumed more than 150 Million doses in 2014. It is predicted that these three vaccines will bolster the usable pattern in the United States.
The United States pediatric vaccines are expected to remain highly active in the future, fueled by the encouragement and financing from Governments and other health organizations.
This is 8th edition report on Vaccines Market & 3rd edition on Pediatric Vaccines Market by Renub Research. Report titled "United States Pediatric Vaccines Market, Doses, Immunization (Vaccinated), Cases & Forecast” talks about the pediatric vaccines. The report provides information on all the Ten (10) Pediatric Vaccines Market, Doses, Number of Children Being Vaccinated and Number of Cases in United States. This report covers in detail all aspects of past, present and future scenario. The report also entails major factors driving the Pediatric vaccines market and challenges of Pediatric vaccines market.
Ten (10) Pediatric Vaccines Covered in this Report are as follows:
1. Measles, Mumps & Rubella (MMR) Vaccines
2. Haemophilus Influenzae Type B (HIB) Vaccines
3. Polio Vaccines
4. Diphtheria Tetanus & Pertussis (DTaP) Vaccines
5. Pneumococcal Vaccines
6. Rotavirus Vaccines
7. Hepatitis B Pediatric Vaccines
8. Hepatitis A Pediatric Vaccines
9. Varicella / Chicken Pox Vaccines
10. Influenza Pediatric Vaccines
All the Pediatric Vaccines in this Report have been studied from Four View Points:
1. Number of Cases
2. Number of Doses
3. Number of Children Being Vaccinated
4. Market Size for all 10 Pediatric Vaccines
Key Topics Covered in the Report
• United States – Pediatric Vaccines Market & Forecast
• United States – Pediatric Vaccines Market Share & Forecast
• United States - Pediatric Disease Cases
• Pediatric Vaccines Doses and Forecast
• Number of Children Being Vaccinated
• Market Size for all 10 Pediatric Vaccines
• Growth Drivers of Pediatric Vaccines Market
• Challenges of Pediatric Vaccines Market
Data Sources
This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non–printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
Click here to view the report Details: http://www.renub.com/report/united-states-pediatric-vaccines-market-doses-immunization-vaccinated-cases-forecast-165
For more information visit: http://www.renub.com/
Contact Us
Rajat Gupta
Sr. Manager
Sales & Marketing Div
Renub Research
Email: rajat.gupta@renub.com
Phone: +1-678-302-0700 (USA), +91-120-421-9822, +91-120-254-5750 (India)
Web: http://www.renub.com
Контактное лицо: Rajat Gupta
Компания: Renub Research
Добавлен: 12:12, 18.06.2015
Количество просмотров: 661
Страна: США
| МираксБиоФарма объявляет о новом этапе развития, МираксБиоФарма, 22:12, 21.06.2025, Россия217 |
| Москва, 17 июня 2025 г
Фармацевтическая компания «МираксБиоФарма» завершила ребрендинг и представила обновлённый логотип, фирменный стиль и стратегию развития. Новый образ компании подчёркивает её амбиции и уникальный подход: создание лекарственных препаратов, БАД и косметических средств по модели полного цикла. |
| Агентство IQ реализовало digital размещение для компании СДЭК, посвящённую их 25-летию, Рекламное агентство IQ, 22:47, 18.06.2025, Россия233 |
| С декабря 2024 по март 2025 года агентством IQ была размещена digital реклама компании СДЭК, посвящённая их 25-летию. Трансляция роликов велась в ключевых курортах России — Шерегеш Сектор А, Б, Е, Красная Поляна и Газпром Поляна, что обеспечило охват целевой аудитории премиального и спортивного сегмента. |
| BTL-интеграция Capital Group: продвижение ЖК Бадаевский через гольф-клуб Раево от агентства IQ, Рекламное агентство IQ, 13:10, 10.06.2025, Россия134 |
| В марте 2025 года агентство IQ реализовало BTL-интеграцию для Capital Group в гольф-клубе Раево, направленную на продвижение жилого комплекса «Бадаевский». Кампания состояла из комплексных условий партнёрства в рамках мероприятия «Масленица в Раево» с брендированием, а также активным участием в программе праздника для привлечения премиальной аудитории. |
|
|
